4 insiders bought €1.3M of shares over the last 90 days, the latest by 강승구, filed 18 Sept 2026.
Who traded when
BuySale+6 other insiders
Since the insiders bought
- -80.2%Entry ₩59,700 · Close 30 Oct 2026 ₩11,810
- -80.2%Entry ₩59,700 · Close 30 Oct 2026 ₩11,810
- -80.2%Entry ₩59,700 · Close 30 Oct 2026 ₩11,810
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 42,000 sharesShareKRXDART:20260918000067Canonical exit: 17 Dec 2026 (T+90)
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 11,500 sharesShareKRXDART:20260819000287Canonical exit: 17 Nov 2026 (T+90)
- 32,000 sharesShareKRXDART:20260819000278Canonical exit: 17 Nov 2026 (T+90)
- 6,000 sharesShareKRXDART:20260819000271Canonical exit: 17 Nov 2026 (T+90)
- 442,500 sharesShareKRXDART:20260729000506Canonical exit: 27 Oct 2026 (T+90)
- Other0DART
- Other0DART
- 11,020 sharesKRXDART:20260701000452
- 267,472 sharesKRXDART:20260610000067
- 20,000 shares@ ₩3,020.000.0092% mcap100.0% of flowShareKRXDART:20260416000399Canonical exit: 12 Jul 2026 (T+90)
- 17,500 shares@ ₩11,625.000.031% mcap100.0% of flowShareKRXDART:20260416000375Canonical exit: 12 Jul 2026 (T+90)
- 20,000 shares@ ₩10,875.000.033% mcap100.0% of flowShareKRXDART:20260416000413Canonical exit: 12 Jul 2026 (T+90)
- 202,914 sharesKRXDART:20260409002795
- ●Executives0DART
- 2,500 sharesShareKRXDART:20260210000511
- 33,000 sharesShareKRXDART:20260210000502
- 45,500 sharesShareKRXDART:20260210000539
- 55,500 sharesShareKRXDART:20260116000404Canonical exit: 16 Apr 2026 (T+90)
- 2,500 sharesShareKRXDART:20260116000390Canonical exit: 16 Apr 2026 (T+90)
25 of 58 declarations
About AprilBio Co.,Ltd.
On April 13, 2026, three filers at 에이프릴바이오 (AprilBio Co.,Ltd.) bought on the same day: 진홍국 (이사) for EUR 125,063, 허병웅 (이사) for EUR 116,977 and 서상준 (고문) for EUR 34,730. These are the only three purchases with an amount in the record, EUR 276,769 in all.
This South Korean health care company, listed on the Korea Exchange, is worth KRW 310.2 billion, and insiders hold 16.5% of the capital. Between July 28, 2022 and September 18, 2026, 14 filers published 50 filings: 28 purchases against 15 sales, or 65% purchases. 유한양행 is the most present filer with 12 filings, 11 purchases and 1 sale; 김진택 (상무이사) has 8.
Read moreShow less
From August 19, 2026 to September 18, 2026, 4 filers bought. The year 2026 has 20 filings, against 5 in 2025. Over the last twelve months there are 22, of which 12 purchases and 9 sales. Overall median delay: 4 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
